GSK Violated Competition Laws: EU Advocate General

Law360, New York (April 1, 2008, 12:00 AM EDT) -- The Court of Justice of the European Communities' advocate general has suggested that the court find GlaxoSmithKline Plc's practice of selling three drugs in Greece on a quota system in order to combat parallel trading a violation of Europe's competition laws.

The advocate general found Tuesday in a nonbinding, advisory opinion that Glaxo subsidiary GlaxoSmithKline AEVE was likely abusing its dominant market position.

In 2000, Glaxo switched from meeting orders from Greek wholesalers for the drugs to supplying drugs directly to hospitals and pharmacies through a...
To view the full article, register now.